WOODBRIDGE, CT
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CURE RARE DISEASE INC, founded in 2018, is a community nonprofit in the Diseases & Disorders sector that reported $5.3M in total revenue in fiscal year 2024. Revenue surged 20% from the prior year, signaling strong growth momentum. The organization ran a surplus of $3.0M, a strong 57% operating margin.
OUR MISSION IS TO ENABLE AND FINANCE THE DEVELOPMENT OF LIFE-SAVING GENETIC MEDICINES FOR ULTRA-RARE PATIENT POPULATIONS PREVIOUSLY DEEMED TOO RARE TO TREAT. TO REALIZE THIS, OUR UNIQUE ECOSYSTEMS FACILITATES COLLABORATION BETWEEN WORLD-RENOWNED RESEARCHERS AND CLINICIANS, POLICY EXPERTS AND OUR GENEROUS DONORS. TOGETHER, WE ARE FUNDAMENTALLY CHANGING THE ULTRA-RARE DISEASE EXPERIENCE AND BURDEN FOR MILLIONS OFPEOPLE AROUND THE WORLD WITH OUR DISCOVERIES AND METHODS - WHILE BRINGING HOPE TO PATIENTS WAITING FOR A CURE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $5,335,620 | $4,438,510 | +0.2% |
| Expenses | $2,307,360 | $2,003,149 | +0.2% |
| Net Income | $3,028,260 | $2,435,361 | +0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| RICHARD HORGAN | FOUNDER & CEO | 40.00 |
Officer
Director
|
$210,041 | $9,903 | $219,944 |
| MARK WARD | CAO | 40.00 |
|
$102,686 | $0 | $102,686 |
| BRENT WARNER | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MARK SMITH | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KWESI ACQUAY | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| STEPHANIE HERZOG | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MIKE WILLIAMS | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JEREMY STERNBERG | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JESSICA CURRAN | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KLAUS VEITINGER | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| GREG KLASSEN | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| CODY TRANBARGER | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MICHELLE WERNER | MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $5,335,620 | $2,307,360 | $9,212,415 | $3,028,260 |
| 2024 | $4,438,510 | $2,003,149 | $5,973,877 | $2,435,361 |
| 2023 | $2,300,944 | $1,957,670 | $3,277,567 | $343,274 |
| 2022 | $2,797,783 | $3,210,905 | $839,519 | $-413,122 |
| 2021 | $2,486,822 | $2,289,134 | $1,470,434 | $197,688 |
| 2020 | $908,188 | $340,271 | $1,000,002 | $567,917 |
Compare CURE RARE DISEASE INC with other nonprofits in Connecticut and across the country.